BAFFR

BAFFR

BAFFR 詳細

Molecule Name
B-cell activating factor receptor
分子の別称
BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R
Drug Development Progress
治験薬の数14
市販薬剤の数0
研究&開発段階NDA/BLA
ターゲットの別称
BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
バックグランド
BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR 製品リスト

Species
  • Human(5)
  • Mouse(3)
  • Cynomolgus(2)
  • Rat(1)
Tag
  • His Tag(4)
  • Fc Tag(3)
  • Fc Tag & Avi Tag(2)
  • His Tag & Avi Tag(1)
  • Llama IgG Fc Tag(1)
Host
  • HEK293(11)
Conjugate
  • Unconjugated(8)
  • Biotin-labeled(3)
Grade
  • RUO(11)
Low Endotoxin
  • Yes(2)
  • No(9)
You Have Viewed 1-10 Of 11 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
BAFFR&CD3 BsAb - 01PCCBispecificHumanized Mouse,NanobodyHematological Malignancy,AutoImmunityBlood tumor,Autoimmune disease
プロジェクト
BAFFR&CD3 BsAb - 01
ステージ
PCC
タイプ
Bispecific
由来
Humanized Mouse,Nanobody
疾患領域
Hematological Malignancy,AutoImmunity
適応症
Blood tumor,Autoimmune disease
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Fully Human BAFF-R Chimeric Antigen Receptor T-Cell (Taihe Chunyu)Phase 2 ClinicalHebei Tahoe Chunyu Biotechnology Co Ltd
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia
詳細
Anti-BAFFR CAR T therapy(The General Hospital Of Tianjin Medical University)BAFFR CARTPhase 2 ClinicalThe General Hospital Of Tianjin Medical University
Myasthenia Gravis; Myositis; Neuromyelitis Optica; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
詳細
ESG-206ESG-206Phase 2 ClinicalShanghai Escugen Biotechnology Co Ltd
Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Purpura, Thrombocytopenic, Idiopathic; Sjogren's Syndrome
詳細
dual anti-CD19/anti-BAFF CAR T-cell therapy (Shanghai YaKe Biotechnology/Zhejiang University)Phase 1 ClinicalShanghai Yake Biotechnology Co Ltd
Autoimmune Diseases; Dermatomyositis; Lupus Erythematosus, Systemic; Nephritis; Neuromyelitis Optica; Scleroderma, Systemic
詳細
SSS-68SSS68; SSS-68Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co Ltd
Glomerulonephritis, IGA
詳細
BAFF-R CAR-T cells therapy (Topcel-KH Pharmaceutical)Phase 1 ClinicalJiangsu Topcel-KH Pharmaceutical Co Ltd
Lymphoma, B-Cell
詳細
BAFFR CAR-T cell therapy (Bio-gene Technology)Phase 1 ClinicalGuangzhou Bio-Gene Technology Co Ltd
Precursor Cell Lymphoblastic Leukemia-Lymphoma
詳細
LY-4152199LY-4152199; LY4152199Phase 1 ClinicalEli Lilly And Company
Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
詳細
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells therapy(Mayo Clinic)MC10029; MC-10029Phase 1 ClinicalMayo Clinic
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell
詳細
CD19-BAFF Targeted CAR T-cells Therapy(YaKe Biotechnology)Phase 1 ClinicalShanghai YaKe Biotechnology Co Ltd, Zhejiang University
Autoimmune Diseases; Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
詳細
KD-6005KD-6005; KD6005Phase 1 ClinicalShanghai Celgen Bio-Pharmaceutical Co Ltd, Shanghai Kanda Bio-Technology Co Ltd
Arthritis, Rheumatoid
詳細
AritinerceptAUR-200; AUR200Phase 1 ClinicalThunderbolt Pharma Inc
Autoimmune Diseases
詳細
JH-013JH-013Phase 1 ClinicalBiotech Pharmaceuticals Co Ltd
Arthritis, Rheumatoid; Hematologic Neoplasms; Lupus Erythematosus, Systemic; Sjogren's Syndrome
詳細
BAFFR-CAR T cell therapy (PeproMene Bio)PMB-101; PMB-CT01Phase 1 ClinicalCity Of Hope National Medical Center, PeproMene Bio Inc
Leukemia, Biphenotypic, Acute; Lymphoma, B-Cell; Lymphoma, Follicular; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
詳細
Customer Reviews